- Home
- VRNT vs OSTX Comparison
VRNT vs OSTX Comparison
Compare VRNT & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- OSTX
- Stock Information
- Founded
- VRNT 1994
- OSTX 2018
- Country
- VRNT United States
- OSTX United States
- Employees
- VRNT N/A
- OSTX N/A
- Industry
- VRNT EDP Services
- OSTX
- Sector
- VRNT Technology
- OSTX
- Exchange
- VRNT Nasdaq
- OSTX NYSE
- Market Cap
- VRNT 1.1B
- OSTX 43.0M
- IPO Year
- VRNT N/A
- OSTX 2024
- Fundamental
- Price
- VRNT $18.85
- OSTX $1.91
- Analyst Decision
- VRNT Buy
- OSTX Strong Buy
- Analyst Count
- VRNT 6
- OSTX 3
- Target Price
- VRNT $30.33
- OSTX $18.00
- AVG Volume (30 Days)
- VRNT 1.7M
- OSTX 364.0K
- Earning Date
- VRNT 06-04-2025
- OSTX 08-14-2025
- Dividend Yield
- VRNT N/A
- OSTX N/A
- EPS Growth
- VRNT 79.53
- OSTX N/A
- EPS
- VRNT 0.84
- OSTX N/A
- Revenue
- VRNT $896,006,000.00
- OSTX N/A
- Revenue This Year
- VRNT $7.65
- OSTX N/A
- Revenue Next Year
- VRNT $5.54
- OSTX N/A
- P/E Ratio
- VRNT $22.85
- OSTX N/A
- Revenue Growth
- VRNT N/A
- OSTX N/A
- 52 Week Low
- VRNT $14.15
- OSTX $1.12
- 52 Week High
- VRNT $37.31
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- VRNT 61.93
- OSTX N/A
- Support Level
- VRNT $16.23
- OSTX N/A
- Resistance Level
- VRNT $19.65
- OSTX N/A
- Average True Range (ATR)
- VRNT 0.80
- OSTX 0.00
- MACD
- VRNT 0.08
- OSTX 0.00
- Stochastic Oscillator
- VRNT 90.67
- OSTX 0.00
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.